Tonix Pharma (NASDAQ: TNXP) reported Q1 EPS of ($2.93), $0.35 worse than the analyst estimate of ($2.58). Revenue for the quarter came in at $6.88 million versus the consensus estimate of $9.2 million.

For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.